- Letter: Hyperglycemia Is Associated with Impaired Muscle Quality in Older Men with Diabetes: The Korean Longitudinal Study on Health and Aging (Diabetes Metab J 2016;40:140-6)
-
Moon JS
- KMID: 2308633
- Diabetes Metab J.
- 2016 Jun;40(3):248-249.
- doi: 10.4093/dmj.2016.40.3.248
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Hypoglycemia: Culprit or Bystander?
-
Hwang YC
- KMID: 2308626
- Diabetes Metab J.
- 2016 Jun;40(3):190-191.
- doi: 10.4093/dmj.2016.40.3.190
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Response: Hyperglycemia Is Associated with Impaired Muscle Quality in Older Men with Diabetes: The Korean Longitudinal Study on Health and Aging (Diabetes Metab J 2016;40:140-6)
-
Yoon JW, Jang HC
- KMID: 2308634
- Diabetes Metab J.
- 2016 Jun;40(3):250-251.
- doi: 10.4093/dmj.2016.40.3.250
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Sarcopenia, Frailty, and Diabetes in Older Adults
-
Jang HC
- KMID: 2308625
- Diabetes Metab J.
- 2016 Jun;40(3):182-189.
- doi: 10.4093/dmj.2016.40.3.182
Populations are aging and the prevalence of diabetes mellitus is increasing tremendously. The number of older people with diabetes is increasing unexpectedly. Aging and diabetes are both risk factors for... -
- CITED
-
- Close
- SHARE
-
- Close
- Are We in the Same Risk of Diabetes Mellitus? Gender- and Age-Specific Epidemiology of Diabetes in 2001 to 2014 in the Korean Population
-
Koo BK, Moon MK
- KMID: 2308624
- Diabetes Metab J.
- 2016 Jun;40(3):175-181.
- doi: 10.4093/dmj.2016.40.3.175
In the early 2000s, the prevalence of diabetes in adults aged ≥30 years in Korea was about 9% to 10%, and it remained stable. However, a nationwide survey showed that... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of Rebamipide on Gastrointestinal Symptoms in Patients with Type 2 Diabetes Mellitus
-
Park S, Park SY, Kim YJ, Hong SM, Chon S, Oh S, Woo JT, Kim SW, Kim YS, Rhee SY
- KMID: 2308632
- Diabetes Metab J.
- 2016 Jun;40(3):240-247.
- doi: 10.4093/dmj.2016.40.3.240
BACKGROUND: Gastrointestinal (GI) symptoms are common in patients with type 2 diabetes mellitus (T2DM). Rebamipide is an effective gastric cytoprotective agent, but there are few data on its usefulness in... -
- CITED
-
- Close
- SHARE
-
- Close
- Severe Hypoglycemia and Cardiovascular or All-Cause Mortality in Patients with Type 2 Diabetes
-
Cha SA, Yun JS, Lim TS, Hwang S, Yim EJ, Song KH, Yoo KD, Park YM, Ahn YB, Ko SH
- KMID: 2308628
- Diabetes Metab J.
- 2016 Jun;40(3):202-210.
- doi: 10.4093/dmj.2016.40.3.202
BACKGROUND: We investigated the association between severe hypoglycemia (SH) and the risk of cardiovascular (CV) or all-cause mortality in patients with type 2 diabetes. METHODS: The study included 1,260 patients aged... -
- CITED
-
- Close
- SHARE
-
- Close
- Renoprotective Effect of Gemigliptin, a Dipeptidyl Peptidase-4 Inhibitor, in Streptozotocin-Induced Type 1 Diabetic Mice
-
Jung GS, Jeon JH, Choe MS, Kim SW, Lee IK, Kim MK, Park KG
- KMID: 2308629
- Diabetes Metab J.
- 2016 Jun;40(3):211-221.
- doi: 10.4093/dmj.2016.40.3.211
BACKGROUND: Dipeptidyl peptidase-4 (DPP-4) inhibitors are widely used in the treatment of patients with type 2 diabetes and have proven protective effects on diabetic kidney disease (DKD). Whether DPP-4 inhibitors... -
- CITED
-
- Close
- SHARE
-
- Close
- Feasibility of a Patient-Centered, Smartphone-Based, Diabetes Care System: A Pilot Study
-
Kim EK, Kwak SH, Baek S, Lee SL, Jang HC, Park KS, Cho YM
- KMID: 2308627
- Diabetes Metab J.
- 2016 Jun;40(3):192-201.
- doi: 10.4093/dmj.2016.40.3.192
BACKGROUND: We developed a patient-centered, smartphone-based, diabetes care system (PSDCS). This study aims to test the feasibility of glycosylated hemoglobin (HbA1c) reduction with the PSDCS. METHODS: This study was a single-arm... -
- CITED
-
- Close
- SHARE
-
- Close
- APO A2 -265T/C Polymorphism Is Associated with Increased Inflammatory Responses in Patients with Type 2 Diabetes Mellitus
-
Koohdani F, Sadrzadeh-Yeganeh H, Djalali M, Eshraghian M, Zamani E, Sotoudeh G, Mansournia MA, Keramat L
- KMID: 2308630
- Diabetes Metab J.
- 2016 Jun;40(3):222-229.
- doi: 10.4093/dmj.2016.40.3.222
BACKGROUND: Apolipoprotein A2 (APO A2) is the second most abundant structural apolipoprotein in high density lipoprotein. Several studies have examined the possible effect of APO A2 on atherosclerosis incidence. Due... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Vildagliptin and Pioglitazone in Korean Patients with Type 2 Diabetes Inadequately Controlled with Metformin
-
Kim JH, Kim SS, Baek HS, Lee IK, Chung DJ, Sohn HS, Bae HY, Kim MK, Park JH, Choi YS, Kim YI, Hahm JR, Lee CW, Jo SR, Park MK, Lee KJ, Kim IJ
- KMID: 2308631
- Diabetes Metab J.
- 2016 Jun;40(3):230-239.
- doi: 10.4093/dmj.2016.40.3.230
BACKGROUND: We compared the efficacies of vildagliptin (50 mg twice daily) relative to pioglitazone (15 mg once daily) as an add-on treatment to metformin for reducing glycosylated hemoglobin (HbA1c) levels... -
- CITED
-
- Close
- SHARE
-
- Close
